Industry

Service ensures that clinicians are properly qualified, consistently trained and monitored throughout the life of a trial MAIDENHEAD, England–(BUSINESS WIRE)–RWS (RWS.L), a global AI solutions company, announces the launch of a new rater training, certification and retraining service designed specifically to improve data quality, consistency and reliability in central nervous system (CNS) clinical trials. The … [Read more…]

The United States (U.S.) Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) resubmission for RelabotulinumtoxinA for the temporary improvement of moderate-to-severe glabellar lines (frown lines) and lateral canthal lines (crow’s feet) in adults RelabotulinumtoxinA is designed to optimize molecule integrity to deliver fast onset of action as early as Day 1 … [Read more…]

NEW YORK–(BUSINESS WIRE)–Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the appointment of Paul Abrams as Vice President of Sales. Abrams will oversee the company’s commercial strategy and execution as Vent Creativity expands adoption of its digital twin platform for orthopedic surgery. Vent Creativity’s software enables surgeons to create a patient-specific … [Read more…]

PARIS–(BUSINESS WIRE)–#AntiAging—Lorient, a premium aesthetic brand, announced that it has drawn global attention at the 27th IMCAS World Congress 2026 in Paris, attracting over 15,000 professionals and demonstrating its leadership in aesthetic innovation. The highlight was a session led by Dr. Jani van Loghem, a globally revered key opinion leader known for establishing international aesthetic … [Read more…]

First-ever approved treatment for CDD in China now set for commercial launch through dedicated rare disease platform SHANGHAI–(BUSINESS WIRE)–Tenacia Biopharmaceuticals (Shanghai) Co., Ltd. (“Tenacia“) and GOLDEN AGE HEALTH (SHANGHAI) CO., LTD., a subsidiary of Golden Age Health Pte. Ltd. (collectively, “GAH“) today announced a Commercialization Agreement granting GAH exclusive rights to commercialize ZTALMY® (泽元安), the … [Read more…]

AIDS Healthcare Foundation (AHF) will open its new Out of the Closet Thrift Store location on Saturday, January 31, 2026 in Chicago’s Hyde Park neighborhood. Local leaders will join AHF executives for a ribbon cutting at 1:00pm at 1709 E. 53rd Street, Chicago, IL. CHICAGO–(BUSINESS WIRE)–Out of the Closet Thrift Store (OTC), the nation’s largest … [Read more…]

Group sued Florida DOH over rules cutting lifesaving HIV/AIDS treatment for thousands FORT LAUDERDALE, Fla.–(BUSINESS WIRE)–Today, AIDS Healthcare Foundation (AHF) asked for and received an expedited hearing schedule in its legal efforts to block harmful changes to Florida’s AIDS Drug Assistance Plan (ADAP). It is estimated that 16,000 Floridians living with HIV/AIDS could lose access … [Read more…]

CHELMSFORD, Mass.–(BUSINESS WIRE)–The Cannabist Company Holdings Inc. (Cboe CA: CBST) (OTCQB: CBSTF) (“The Cannabist Company” or “the Company”), one of the most experienced cultivators, manufacturers and retailers of cannabis products in the United States, today announced that it has entered into a forbearance agreement (the “Forbearance Agreement”), with an ad hoc group of noteholders (the … [Read more…]

Amtelco proudly celebrates its 50th anniversary this year, commemorating five decades of invention, growth, and commitment to the call center industry. MCFARLAND, Wis.–(BUSINESS WIRE)–#AI–Amtelco, a leader in the call center industry, announced it is celebrating its 50th anniversary, recognizing half a century of commitment to providing innovative communication tools and software built on tradition. This … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “GLP-1 Analogues Market” report has been added to ResearchAndMarkets.com’s offering. This report provides detailed information on glucagon-like peptide-1 (GLP-1) analogues. It analyzes market trends for GLP-1 analogues, with data from 2024, estimates from 2025, projections of compound annual growth rates (CAGRs) through 2030 (the forecast period 2025-2030) and regional markets for GLP-1 analogues. … [Read more…]